Show simple item record

Rationale for Cotargeting Hepatocyte Growth Factor and Epidermal Growth Factor Receptor in Recurrent/Metastatic Head and Neck Cancer.

dc.contributor.authorKermorgant, Sen_US
dc.date.accessioned2024-01-15T14:21:49Z
dc.date.issued2023-08-01en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/93902
dc.format.extent3863 - 3866en_US
dc.languageengen_US
dc.relation.ispartofJ Clin Oncolen_US
dc.subjectHumansen_US
dc.subjectHepatocyte Growth Factoren_US
dc.subjectNeoplasm Recurrence, Localen_US
dc.subjectErbB Receptorsen_US
dc.subjectHead and Neck Neoplasmsen_US
dc.titleRationale for Cotargeting Hepatocyte Growth Factor and Epidermal Growth Factor Receptor in Recurrent/Metastatic Head and Neck Cancer.en_US
dc.typeArticle
dc.identifier.doi10.1200/JCO.23.00460en_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/37319388en_US
pubs.issue22en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume41en_US
qmul.funderUnravelling c-Met signalling from autophagic endomembranes::Medical Research Councilen_US


Files in this item

Thumbnail
Name:
kermorgant-2023-rationale-for- ...
Size:
268.3Kb
Format:
application/
Description:
Published version
View/Open

This item appears in the following Collection(s)

Show simple item record